BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16174982)

  • 1. Liver support therapy: an overview of the AMC-bioartificial liver research.
    van de Kerkhove MP; Poyck PP; Deurholt T; Hoekstra R; Chamuleau RA; van Gulik TM
    Dig Surg; 2005; 22(4):254-64. PubMed ID: 16174982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioartificial liver: its pros and cons.
    Chamuleau RA; Poyck PP; van de Kerkhove MP
    Ther Apher Dial; 2006 Apr; 10(2):168-74. PubMed ID: 16684219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of bioartificial liver support systems.
    van de Kerkhove MP; Hoekstra R; Chamuleau RA; van Gulik TM
    Ann Surg; 2004 Aug; 240(2):216-30. PubMed ID: 15273544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver.
    van de Kerkhove MP; Di Florio E; Scuderi V; Mancini A; Belli A; Bracco A; Scala D; Scala S; Zeuli L; Di Nicuolo G; Amoroso P; Calise F; Chamuleau RA
    Cell Transplant; 2003; 12(6):563-8. PubMed ID: 14579924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical trial with the AMC-bioartificial liver.
    van de Kerkhove MP; Di Florio E; Scuderi V; Mancini A; Belli A; Bracco A; Dauri M; Tisone G; Di Nicuolo G; Amoroso P; Spadari A; Lombardi G; Hoekstra R; Calise F; Chamuleau RA
    Int J Artif Organs; 2002 Oct; 25(10):950-9. PubMed ID: 12456036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver.
    Di Nicuolo G; van de Kerkhove MP; Hoekstra R; Beld MG; Amoroso P; Battisti S; Starace M; di Florio E; Scuderi V; Scala S; Bracco A; Mancini A; Chamuleau RA; Calise F
    Xenotransplantation; 2005 Jul; 12(4):286-92. PubMed ID: 15943777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ['Artificial support in case of hepatic failure'; a report from the Dutch Health Council].
    Chamuleau RA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):221-3. PubMed ID: 15719830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological and non-biological elimination therapy of acute liver failure. Experimental study on large laboratory animal].
    Ryska M; Lásziková E; Pantoflícek T; Kieslichová E; Ryska O; Prazák J; Koblihová E; Skibová J
    Cas Lek Cesk; 2008; 147(7):367-75. PubMed ID: 18678095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic assist devices.
    Demetriou AA
    Panminerva Med; 2005 Mar; 47(1):31-7. PubMed ID: 15985975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.
    Poyck PP; Hoekstra R; van Wijk AC; Attanasio C; Calise F; Chamuleau RA; van Gulik TM
    Liver Transpl; 2007 Apr; 13(4):589-98. PubMed ID: 17394165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature.
    He YT; Qi YN; Zhang BQ; Li JB; Bao J
    World J Gastroenterol; 2019 Jul; 25(27):3634-3648. PubMed ID: 31367162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Liver Int; 2013 Apr; 33(4):516-24. PubMed ID: 23387413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.
    Weng J; Han X; Zeng F; Zhang Y; Feng L; Cai L; Liang K; Liu S; Li S; Fu G; Zeng M; Gao Y
    Theranostics; 2021; 11(16):7620-7639. PubMed ID: 34335954
    [No Abstract]   [Full Text] [Related]  

  • 15. Artificial and bioartificial liver support.
    McKenzie TJ; Lillegard JB; Nyberg SL
    Semin Liver Dis; 2008 May; 28(2):210-7. PubMed ID: 18452120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.
    Shi XL; Gao Y; Yan Y; Ma H; Sun L; Huang P; Ni X; Zhang L; Zhao X; Ren H; Hu D; Zhou Y; Tian F; Ji Y; Cheng X; Pan G; Ding YT; Hui L
    Cell Res; 2016 Feb; 26(2):206-16. PubMed ID: 26768767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical issues in bioartificial liver development.
    Tilles AW; Berthiaume F; Yarmush ML; Toner M
    Technol Health Care; 2002; 10(3-4):177-86. PubMed ID: 12118141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bioartificial and artificial liver support devices.
    Hughes RD; Williams R
    Semin Liver Dis; 1996 Nov; 16(4):435-44. PubMed ID: 9027956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New devices in liver replacement therapy].
    Rifai K; Bahr MJ; Schneider A; Ott M; Manns MP
    Med Klin (Munich); 2003 Dec; 98(12):750-3. PubMed ID: 14685676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.